Common Contracts
4 similar Security Agreement contracts by Adma Biologics, Inc., Foamix Pharmaceuticals Ltd., Menlo Therapeutics Inc., Neuronetics, Inc.
FORM OF SECURITY AGREEMENTSecurity Agreement • July 30th, 2024 • Neuronetics, Inc. • Surgical & medical instruments & apparatus • New York
THIS SECURITY AGREEMENT (this “Agreement”), dated as of July 25, 2024, is made by and among Neuronetics, Inc., a Delaware corporation (the “Borrower”), certain Subsidiaries of the Borrower that may be required to become acceded hereto pursuant to Section 22 (each a “Subsidiary Guarantor” and, together with the Borrower, each a “Grantor” and, collectively, the “Grantors”), and Perceptive Credit Holdings IV, LP, as administrative agent for the Lenders (in such capacity, together with its successors and assigns, the “Administrative Agent”).
AMENDED AND RESTATED SECURITY AGREEMENTSecurity Agreement • May 11th, 2020 • Menlo Therapeutics Inc. • Pharmaceutical preparations • New York
THIS AMENDED AND RESTATED SECURITY AGREEMENT (as amended, amended and restated, supplemented or otherwise modified from time to time, this “Agreement”), dated as of March _9, 2020, is made by and among Foamix Pharmaceuticals Inc., a Delaware corporation (the “Borrower”), Menlo Therapeutics Inc., a Delaware corporation (the “Parent Guarantor”), Foamix Pharmaceuticals Ltd., an Israeli limited liability company (the “Israeli Guarantor”), certain Subsidiaries of the Parent Guarantor party hereto or having acceded hereto pursuant to Section 22 (each a “Subsidiary Guarantor” and, together with the Parent Guarantor and the Israeli Guarantor, the “Guarantors”, and together with the Borrower, each a “Grantor” and, collectively, the “Grantors”), and PERCEPTIVE CREDIT HOLDINGS II, LP, as administrative agent for the Lenders referred to below (in such capacity, the “Administrative Agent”).
SECURITY AGREEMENTSecurity Agreement • November 12th, 2019 • Foamix Pharmaceuticals Ltd. • Medicinal chemicals & botanical products • New York
THIS SECURITY AGREEMENT (this “Agreement”), dated as of July 29, 2019, is made by and among Foamix Pharmaceuticals Inc., a Delaware corporation (the “Borrower”), Foamix Pharmaceuticals Ltd., an Israeli limited liability company (the “Parent Guarantor”), certain Subsidiaries of the Parent Guarantor party hereto or having acceded hereto pursuant to Section 22 (each a “Subsidiary Guarantor” and, together with the Parent Guarantor, the “Guarantors”, and together with the Borrower, each a “Grantor” and, collectively, the “Grantors”), and PERCEPTIVE CREDIT HOLDINGS II, LP, as administrative agent for the Lenders referred to below (in such capacity, the “Administrative Agent”).
SECURITY AGREEMENTSecurity Agreement • February 12th, 2019 • Adma Biologics, Inc. • Biological products, (no disgnostic substances) • New York
THIS SECURITY AGREEMENT (this “Agreement”), dated as of February 11, 2019, is made by and among ADMA BIOLOGICS, INC., a Delaware corporation (the “Borrower”), certain of the Borrower’s Subsidiaries named in the signature pages hereto or having acceded hereto pursuant to Section 24 (each a “Subsidiary Guarantor” and, together with the Borrower, each a “Grantor” and, collectively, the “Grantors”), and PERCEPTIVE CREDIT HOLDINGS II, LP, as administrative agent for the Lenders referred to below (in such capacity, together with its successors and assigns, the “Administrative Agent”).
